FDA Inspection 965150 — Acadia Pharmaceuticals Inc.
The FDA completed an inspection of Acadia Pharmaceuticals Inc. on Feb 17, 2016 in San Diego, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 17, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Diego, CA (United States)
Additional Details
Sponsor, Contract Research Organization
Citations
| ID | CFR | Description |
|---|---|---|
| 7479 | 21 CFR 312.56(a) | Monitoring investigations |
| 7482 | 21 CFR 312.50 | General responsibilities of sponsors |